Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het forum
Lees Voor (ReadSpeaker)    A-   A+
Over | Zoeken | Contact | Forum
PayPal, de veilige en complete manier van online betalen.

iDeal is onderdeel van de
Franz Schelling Stichting
meer informatie
Sunday, May 13, 2012 5:00 AM | Rodney Davis Volg link

The global market for multiple sclerosis is currently worth about $12 billion, he said. About 2.5 million people are estimated to have the disease worldwide.

"It looks like BG-12 is the best drug," said Eric Schmidt, an analyst at Cowen and Co, who predicts peak annual sales of about $3 billion. "There are still some things we don't know about its long-term safety, but I think it's possible BG-12 will be the biggest MS treatment in the future."

The link: